AdaptHealth’s Strategic Refinancing for Growth and Efficiency
TipRanks (Mon, 16-Sep 8:58 AM ET)
AdaptHealth Corp. to Participate in the Baird 2024 Global Healthcare Conference
Business Wire (Tue, 27-Aug 8:30 AM ET)
AdaptHealth Corp. Announces New Chief Operating Officer
Business Wire (Mon, 26-Aug 7:30 AM ET)
AdaptHealth Corp. to Participate in the Canaccord Genuity 44th Annual Growth Conference
Business Wire (Thu, 8-Aug 4:05 PM ET)
AdaptHealth Corp. Announces Second Quarter 2024 Results
Business Wire (Tue, 6-Aug 7:00 AM ET)
AdaptHealth Corp. Announces Second Quarter 2024 Earnings Release Date and Conference Call
Business Wire (Tue, 16-Jul 8:30 AM ET)
AdaptHealth Corp. Announces Changes to Board of Directors and Management
Business Wire (Tue, 2-Jul 5:21 PM ET)
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Adapthealth Corp. trades on the NASDAQ stock market under the symbol AHCO.
As of September 18, 2024, AHCO stock price declined to $11.33 with 1,130,511 million shares trading.
AHCO has a beta of 1.45, meaning it tends to be more sensitive to market movements. AHCO has a correlation of 0.09 to the broad based SPY ETF.
AHCO has a market cap of $1.52 billion. This is considered a Small Cap stock.
Last quarter Adapthealth Corp. reported $806 million in Revenue and $.17 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.01.
In the last 3 years, AHCO stock traded as high as $28.75 and as low as $6.37.
The top ETF exchange traded funds that AHCO belongs to (by Net Assets): IJR, IWM, VTI, VB, VXF.
AHCO has underperformed the market in the last year with a return of +16.3%, while the SPY ETF gained +27.8%. In the last 3 month period, AHCO fell short of the market, returning +0.4%, while SPY returned +2.9%. However, in the most recent 2 weeks AHCO has outperformed the stock market by returning +4.1%, while SPY returned +1.7%.
AHCO support price is $11.14 and resistance is $11.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AHCO stock will trade within this expected range on the day.